Finance

Beta
Lists
059210:KOSDAQ
Metabiomed Co Ltd
₩3,680.00
+4.25%
(+150.00) 1D
Jun 11, 10:18:03 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 059210...
Open
₩3,455
High
₩3,700
Low
₩3,455
Mkt. cap
99.99B
Avg. vol.
220.72K
Volume
51.55K
Dividend
2.85%
Quarterly dividend
₩26
Ex-dividend date
Dec 27, 2024
P/E ratio
11.18
52-wk high
₩6,600
52-wk low
₩3,300
EPS
₩329
Shares outstanding
27.17M
No. of employees
305
Open
₩3,455
High
₩3,700
Low
₩3,455
Mkt. cap
99.99B
Avg. vol.
220.72K
Volume
51.55K
Dividend
2.85%
Quarterly dividend
₩26
Ex-dividend date
Dec 27, 2024
P/E ratio
11.18
52-wk high
₩6,600
52-wk low
₩3,300
EPS
₩329
Shares outstanding
27.17M
No. of employees
305
News stories
From sources across the web
About Metabiomed Co Ltd
CEO-
Employees305
Founded1990
Headquarters-
SectorMedical device
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
25.47B
23.53B
26.24B
24.42B
Cost of goods sold
9.84B
10.92B
14.09B
11.46B
Cost of revenue
9.84B
10.92B
14.09B
11.46B
Research and development expenses
989.08M
1.34B
1.77B
1.26B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.50B
6.08B
7.42B
6.48B
Operating expense
7.84B
7.54B
9.45B
8.11B
Total operating expenses
17.68B
18.45B
23.54B
19.57B
Operating income
7.79B
5.08B
2.70B
4.85B
Other non operating income
-5.35B
-97.64M
-1.29B
-1.06B
EBT including unusual items
-41.37M
5.79B
921.97M
4.69B
EBT excluding unusual items
941.88M
5.28B
1.85B
5.09B
Income tax expense
842.98M
1.33B
-629.63M
299.35M
Effective tax rate
-2,037.81%
23.02%
-68.29%
6.38%
Other operating expenses
-
-
-
-
Net income
-876.95M
4.46B
1.67B
4.52B
Net profit margin
-3.44%
18.96%
6.38%
18.52%
Earnings per share
-
143.00
-
-
Interest and investment income
330.06M
267.85M
260.77M
207.65M
Interest expense
-768.87M
-583.98M
-513.70M
-487.40M
Net interest expenses
-438.81M
-316.13M
-252.93M
-279.75M
Depreciation and amortization charges
362.94M
309.89M
135.77M
313.61M
EBITDA
9.21B
6.50B
4.20B
6.27B
Gain or loss from assets sale
-110.11M
941.46M
-638.84M
-618.30K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more